SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-321739
Filing Date
2018-11-08
Accepted
2018-11-08 06:09:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d621826d424b5.htm 424B5 658227
2 GRAPHIC g621826g08p19.jpg GRAPHIC 36877
3 GRAPHIC g621826g55y94.jpg GRAPHIC 131358
4 GRAPHIC g621826g73o18.jpg GRAPHIC 7182
5 GRAPHIC g621826g90u03.jpg GRAPHIC 24847
  Complete submission text file 0001193125-18-321739.txt   935588
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-209709 | Film No.: 181168008
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1